Pro-Dex, Inc. PDEX NASDAQ

Pro-Dex, Inc. (PDEX) reported total assets of $61.19M and total liabilities of $24.56M for fiscal year 2025, resulting in total equity of $36.63M.

The company held $7.16M in cash and short-term investments. Total debt stood at $16.58M, with net debt of $16.16M. The Debt-to-Equity (D/E) ratio was 0.45 (conservative).

Current ratio is 3.23, indicating strong short-term liquidity. Interest coverage is 12.9x (strong).

Criteria supported by this page:

• HEALTH (100/100, Pass) — Debt-to-Equity of 0.45, current ratio of 3.23, interest coverage 12.9x — balance sheet is strong
• MOAT (25/100) — Total assets $61.19M and equity $36.63M support the company's competitive scale
• VALUE (30/100) — Debt-to-Equity 0.45 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 71/100 with 4/7 criteria passed.

SAUHY

Straumann Holding AG

$11.28

+1.08%

CLPBY

Coloplast A/S

$6.80

+0.59%

BDXB

Becton, Dickinson and Company

$48.16

+1.39%

LMAT

LeMaitre Vascular, Inc.

$114.81

-2.20%

ATRI

Atrion Corporation

$459.92

+0.06%

OPSSF

Opsens Inc.

$2.14

+0.65%

UTMD

Utah Medical Products, Inc.

$68.80

+0.63%

INFU

InfuSystem Holdings, Inc.

$10.20

+2.13%